NDC 81483-0039

This exact product or package identity exists in FDA auxiliary data but is not present in the current primary NDC product table. The package identity is preserved; status rows are reported source observations, not medical conclusions.

Requested NDC: 81483-0039
Product root: 81483-0039
Identity scope: Product
Primary current NDC product row: Not present

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
compounder	package	81483-0039	81483-0039-0	COMPOUNDER	Outsourcing facility compounded drug report	2026-1	2026-09-18
compounder	package	81483-0039	81483-0039-0	COMPOUNDER	Outsourcing facility compounded drug report	2026-1	2026-10-06

Compounder NDC reports#

Browse the complete compounder directory for this NDC · Browse every current compounder row in the unified auxiliary catalog · browse compounder source captures and parsed snapshots.

Establishment, FEI, Product NDC table
Establishment	FEI	Product NDC	Package NDC	Product	Active ingredients	Reporting period	Normalization
TAILSTORM HEALTH INC DBA MEDIVANT HEALTHCARE		81483-0039	81483-0039-0	LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE	5 ug/1 mL; 20 mg/1 mL	2026-1	valid
TAILSTORM HEALTH INC DBA MEDIVANT HEALTHCARE	167439715	81483-0039	81483-0039-0	Epinephrine Bitartrate; Lidocaine Hydrochloride	5 ug/1 mL; 20 mg/1 mL	2026-1	valid

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.